Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2012-10-25

Clinical Trial Update: The Antioxidant Effect of Routine Vascular Therapy for Normal Tension Glaucoma Patients

View source ↗

Summary

The clinical trial NCT00465348 investigating the antioxidant effect of routine vascular therapy in normal tension glaucoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Primary Open Angle Glaucoma | Status: WITHDRAWN